Basic Data. Birthday: Gender:Female Admission date:

Similar documents
Pre-operative assessment of patients for cytoreduction and HIPEC

Disseminated Peritoneal Adenomucinosis Associated with a Panperitonitis-Like Onset: Report of a Case

Patient Presentation. 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201

Specialised Services Policy: CP02 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery for treatment of Pseudomyxoma Peritonei

Management of Pseudomyxoma Peritonei (PMP) and Colon Cancer Carcinomatosis by Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Appendix cancer mimicking ovarian cancer

International Journal of Health Sciences and Research ISSN:

Clinicopathological features and prognosis of pseudomyxoma peritonei

Information for health professionals - pseudomyxoma peritonei

Joseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital

Clinical Study Laparoscopic Cytoreductive Surgery and HIPEC in Patients with Limited Pseudomyxoma Peritonei of Appendiceal Origin

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE

Clinical presentation of the pseudomyxoma peritonei syndrome

HIPEC Controversies in the Indications and Application of Regional Chemotherapy for Peritoneal Surface Malignancies

TUMOR AND TUMOR-LIKE CONDITIONS OF THE PERITONEUM AND OMENTUM/MESENTERY 40 th. Annual Meeting SCBTMR September 9-13, 2017, Nashville, Tennessee

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

General history. Basic Data : Age :62y/o Date of admitted: Married status : Married

Qué operar y que no operar en carcinomatosis peritoneal. Indicaciones y límites.

Surgical Oncology, Mercy Medical Center, Baltimore, MD

Sex: 女 Age: 51 Occupation: 無 Admission date:92/07/22

Synchronous mucinous tumors of the ovary and the appendix associated with pseudomyxoma peritonei: CT findings

Management of an Appendiceal Mass - Approach to acute presentation of appendiceal neoplasms

Review Article Pulmonary Metastasis from Pseudomyxoma Peritonei

International Society of Gynecological Pathologists Symposium 2007

Syllabus. Appendiceal GCC and LAMN Navigating the Alphabet Soup in the Appendix. Appendiceal tumors. Summary provided Complete presentation

GOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles

Low-grade serous neoplasia. Robert A. Soslow, MD

GENERAL DATA. Sex : female Age : 40 years old Marriage status : married

Corporate Medical Policy

GOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles

GOBLET CELL CARCINOID

Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies

Chapter 6 Frozen Section Evaluation of the Appendix

World Journal of Colorectal Surgery

David Nunns on behalf of the Gynae Guidelines Group Date:

Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies

Heated Intraperitoneal Chemotherapy (HIPEC) for Advanced Abdominal Cancers

Birthday: 1952/07/31 Date of admission:1999/12/30 Age:48 y/o Past medication:esrd under regular HD for 5+ years; denied DM and HTN

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

EDUCATIONAL COMMENTARY CA 125. Learning Outcomes

Planned relaparotomy following curative resection of a locally advanced gastrointestinal cancer

Pseudomyxoma peritoni et al HOW TO TREAT PERITONEAL MALIGNANCIES

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Pseudomyxoma Peritonei - What every radiologist should know

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

MP Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for Rare Peritoneal Disease. Results of the French multicentric database

Pseudomyxoma peritonei: A Review

A Case of Mucinous Cystadenocarcinoma Ovary Mimicking Psuedomyxoma Peritonei

INTRAPERITONEAL CHEMOTHERAPY, CYTOREDUCTION

Review of a Personal Experience in the Management of Carcinomatosis and Sarcomatosis

Part 3. Case #7 History:

Joseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital

Appendix adenocarcinomas are rare and heterogeneous

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC)

Pseudomyxoma Peritonei: A Case Report of an Incidental Finding at Cesarean Section

Brief History. Identification : Past History : HTN without regular treatment.

Mucinous tumours of appendix and ovary: an overview and evaluation of current practice

Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature

Staging and Treatment Update for Gynecologic Malignancies

Cytoreduction including total gastrectomy for pseudomyxoma peritonei

Patient Information. Age: 8 y/o Sex: Female. Date of Admission: Date of Discharge:

Kathleen A. Cummins 1, Gregory B. Russell 2, Konstantinos I. Votanopoulos 1, Perry Shen 1, John H. Stewart 1, Edward A. Levine 1.

Stage 3 ovarian cancer survival rate

Borderline ovarian tumors comprise about 15% to

Stage 3 ovarian cancer survival rate

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Case Scenario 1. History

Winship Cancer Institute of Emory University Optimizing First Line Treatment of Advanced Ovarian Cancer

MP Hyperthermic Intraperitoneal Chemotherapy for Select IntraAbdominal and Pelvic Malignancies. Related Policies None

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies

Vic J. Verwaal, MD, PhD, 1 Sjoerd Bruin, MD, 1 Henk Boot, MD, PhD, 2 Gooike van Slooten, MD, 1 and Harm van Tinteren, ScM 3

Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122

Clinical Policy: Intraperitoneal Hyperthermic Chemotherapy for Abdominopelvic Cancers Reference Number: CP.MP. 346

Caeco-colic Intussusception Simulating an Appendicular Mass

Despite advances in our understanding of appendiceal. An Update on the Diagnosis, Grading, and Staging of Appendiceal Mucinous Neoplasms

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

AJCC Staging Case Scenario #1

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

Chief Complaint. Retroperitoneal cystic mass incidentally found at health examination center.

Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasis

Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors

Perforation of a Duodenal Diverticulum. Elective Student S. C.

Alejandro Cracco, Mayank Roy, Conrad H. Simpfendorfer. Introduction

Ovarian Tumors. Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center

L/O/G/O. Ovarian Tumor. Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital

Endometriosis of the Appendix Resulting in Perforated Appendicitis

FDG-PET/CT in Gynaecologic Cancers

Case report Serous cystadenocarcinoma of the mesentery in a man: case report and review of literature

Pseudomyxoma peritonei of 92 Chinese patients: Clinical characteristics, pathological classification and prognostic factors

Borderline tumors. Borderline tumors. Serous borderline tumor are NOT benign. Low grade serous carcinoma: pathogenesis. Serous carcinoma: pathogenesis

Results of CRS and HIPEC in. Colorectal PSM. and. Pseudomyxoma Peritonei

Chapter 2 Intraoperative Evaluation for Extracolonic Disease in Colon Cancer Patients

Transcription:

Basic Data Birthday:1951-07-02 Gender:Female Admission date:2004-06-28

Chief Complaint A protruding mass over RLQ abdomen for many years.

Present Illness & Past History Pseudomyxoma peritonei s/p laparotomy and debulking of adhesion at Chung Shin Municiple hospital on 2003-08-26. CEA:11.93, CA199:102.7 at our OPD for cancer follow up on 2004-06-17. DM for 1~2 years under regular control. HTN for 1~2 years under regular control.

Review of systems & PE Review of systems:no specific findings Physical examination: Abdomen:4x4 fixed palpable mass

Lab Data 採樣時間 2004-06-17 CEA (< 4.6 ng/ml) 11.93 CA199 (< 37 U/ml) 102.70

Lab Data 檢驗日期 2004-06-28 WBC RBC Hb 3600/uL 3.17 (10 6 /ul) 10.6 g/dl Hct 33% MCV 104.1 fl

Image Findings-CT pre-contrast

Image Findings-CT post-contrast

Image Findings-Conclusion Multiple non-enhanced intraperitoneal masses (HU:22~25) Bowel wall thickening and folds swelling Impression:Pseudomyxoma peritonei

Image Findings-D/D Ascites. Sclerosing peritonitis. Intraperitoneal abscess. Retroperitoneal lymphadenopathy.

First Impression Recurrent pseudomyxoma peritonei

Operation Findings 2004-07-02 R t hemicolectomy Hartmann s procedure Debulking of tumor

Pathological Findings-Grossly R t hemicolectomy Marked fibrous adhesion and mucinous tumor involving on the serosa and the omentum are noted. Hartmann s procedure The outer surface of the colon also shows marked mucinous tumor coating and fibrous adhesion. Debulking Mucinous substance admixed with adipose tissue All the tumor is limited to serosa and subserosal areas. Impression:Pseudomyxoma peritonei

Pathological Findings-Microscopically Large mucin pools Only a few mucin pools have an epithelial lining Some mucin-producing cells are arranged in glands, nests, or ribbons. Benign in appearance No invasive components Frozen diagnosis:pseudomyxoma Peritonei

Final Diagnosis Recurrent Pseudomyxoma Peritonei

Discussion Pseudomyxoma Peritonei

Introduction Pseudomyxoma Peritonei is a slowly progressive disease that produces extensive mucus accumulation within the abdomen and pelvis.

Symptoms & Signs Gradual increase in abdominal girth. The increase of intraperitoneal pressure prevents the patient from eating normally. Increase in body weight.

Histological classification of mucinous lesions DPAM-disseminated peritoneal adenomucinosis PMCA-peritoneal mucinous carcinomatosis Hybrid tumor From:Mod pathol 2001;14:664-671 Abstract quote

Pathogenesis MUC2-expressing goblet cell From:Am J Pathol 2002 Aug;161(2):551-64 Abstract quote

Tumor Markers For diagnosis and follow-up CEA (75%) & CA199 (58%) CA199 was shown to be a more useful tumor marker than CEA for follow-up. From:Ann Surg Oncol. 2002 Dec;9(10):961-7. Abstract quote

Image-CT Multiple low-attenuation masses within the peritoneal cavity Scalloping of the liver margin Calcifications

http://www.surgicaloncology.com/atct.htm

Treatment Watch and wait Monitor the situation closely Surgery Systemic chemotherapy The evidence for the use of systemic chemotherapy in the management of pseudomyxoma peritonei has yet to be established

Surgery Debulking Traditional surgical approach High recurrent rate Cytoreductive surgery plus peri-operative chemotherapy(hipec) Aggressive removal or destruction of all visible tumors After cytoreduction, chemotherapy is administered directly into the peritoneal cavity.

Post-operative Mortality & Morbidity Mortality rates of complete cytoreduction:3~5% Main complication:lung infections and heart failure Other complications:clots in main leg vein Significant morbidity:30% 20% of patients require further surgery 20% of patients need a stoma Leakage of anastomosis

Prognosis Prognostic factor for survival Completeness of cytoreduction (P<0.0001) Histopathological charater (P<0.001) Extent of previous surgical interventions (P=0.001) From:Eur J Surg Oncol 2001 Apr;27(3):239-43 Abstract quote

Prognosis Survival rates 5 years 10 years DPAM 75% 68% PMCA-I/D 50% 21% PMCA 14% 3% From:Cancer 2001 Jul 1;92(1):85-91 Abstract quote

Prognosis From:Mod Pathol 2001;14:164-171 Abstract quote Unsuccessful second-look surgery is often related to an inaccurate initial histologic classification of appendiceal mucinous tumor. Assessment of tumor histology can predict the outcome if a uniform surgical treatment is used in patients

The End

Ascites Low density fluid accumulation Common sites: Douglas pouch Morrison s pouch Paracolic gutter Retroperitoneal free.

Sclerosing Peritonitis Adhesion Calcifications.

Intraperitoneal Abscess Air-fluid level Thin enhanced wall.

Retroperitoneal Lymphadenopathy Over lymph node chain.

Strips of mucinous epithelium with minimal cytologic atypia are found associated with pools of mucin and fibrous tissue. (H&E). Ronnett BM, Schmookler BM, Sugarbaker PH, Kurman RJ: Pseudomyxoma peritonei: New concepts in diagnosis, origin, nomeclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. In: Fechner RE, Rosen PP (Eds): Anatomic Pathology 1997 ASCP Press, Chicago, IL, 1997.